China Healthcare Sector Report 2017 3rd Quarter

  • ID: 4483571
  • Report
  • Region: China
  • 69 pages
  • EMIS, A Euromoney Institutional Investor Company
1 of 5
Nearly 40% of Hospitals’ Revenue in China is Generated by Pharmaceutical Sales

FEATURED COMPANIES

  • Aier Eye Hospital Group
  • Phoenix Healthcare Group
  • Zhejiang Dian Diagnostics
  • MORE
This report provides a complete and detailed analysis of the healthcare sector for China. The author presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:
  • Understand the key elements at play in the healthcare sector in China
  • Assess market for growth in the sector
  • View key data on healthcare spending and health insurance in China
  • Crystallise the forces both driving and restraining this sector in China
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in China
  • Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aier Eye Hospital Group
  • Phoenix Healthcare Group
  • Zhejiang Dian Diagnostics
  • MORE
1. Executive Summary
  • Sector in Numbers
  • Sector Overview
  • Sector Snapshot
  • Driving Forces
  • Restraining Forces
2. Sector in Focus Quarterly Update
  • Focus Point - China Healthcare Sector Q2 2017
  • Quarterly Summary
  • Sector Outlook
  • Sector Highlights
  • Main Sector Indicators
  • Top M&A Deals
  • M&A Activity
3. Competitive Landscape
  • Highlights
  • Top Listed Companies
  • Medical Institutions
  • Competition Elements
  • Foreign Investment
4. Companies in Focus
  • Xi'an International Medical Investment
  • Hua Xia Healthcare Holdings
  • Aier Eye Hospital Group
  • Zhejiang Dian Diagnostics
  • Phoenix Healthcare Group
5. Regulatory Environment
  • Government Policy
6. Medical Institutions
  • Focus Point - Hospital Visits by Province
  • Highlights
  • Key Indicators
  • Number of Type of Hospitals
  • Foreign-Owned Private Hospitals
7. Medical Devices
  • Highlights
  • Sales Revenue
  • External Trade
8. Health Insurance
  • Focus Point - Health Insurance in China
  • Highlights
  • Health Insurance
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Aier Eye Hospital Group
  • Phoenix Healthcare Group
  • Zhejiang Dian Diagnostics
  • MORE
China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is generated by pharmaceutical sales. The Chinese healthcare market has been growing strongly, focusing on the treatment of chronic diseases such as cancer, diabetes and respiratory conditions. China's current shortage of quality public healthcare services has resulted in rising demand for private medical care. However, private healthcare is underdeveloped and faces difficulties in finding experienced doctors, as many of them are employed by public hospitals under exclusivity clauses.
Note: Product cover images may vary from those shown
5 of 5
  • Xi'an International Medical Investment
  • Hua Xia Healthcare Holdings
  • Aier Eye Hospital Group
  • Zhejiang Dian Diagnostics
  • Phoenix Healthcare Group
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll